Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a cash flow conversion efficiency ratio of -0.212x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-19.96 Million ≈ $-2.92 Million USD) by net assets (CN¥94.30 Million ≈ $13.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Hangzhou TianMuShan Pharmaceutical Enter to measure how many days the company can operate on defensive assets alone.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BRC Group Holdings, Inc.
NASDAQ:RILY
|
1.643x |
|
New Providence Acquisition Corp. III Class A Ordinary Shares
NASDAQ:NPAC
|
-0.001x |
|
Guangzhou Tech-Long Packing Machine Co Ltd
SHE:002209
|
0.134x |
|
Patel Engineering Limited
NSE:PATELENG
|
0.097x |
|
Unitech Computer Co Ltd
TW:2414
|
0.057x |
|
Ld Intelligent Technology Co Ltd
SHE:300883
|
0.008x |
|
Tus Pharmaceutical Group Co Ltd
SHE:000590
|
0.004x |
|
Global Standard Technology Limited
KQ:083450
|
0.015x |
Annual Cash Flow Conversion Efficiency for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Hangzhou TianMuShan Pharmaceutical Enter (600671) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥93.99 Million ≈ $13.75 Million |
CN¥11.79 Million ≈ $1.73 Million |
0.125x | +129.08% |
| 2024-12-31 | CN¥85.02 Million ≈ $12.44 Million |
CN¥-36.67 Million ≈ $-5.37 Million |
-0.431x | -18.14% |
| 2023-12-31 | CN¥55.95 Million ≈ $8.19 Million |
CN¥-20.43 Million ≈ $-2.99 Million |
-0.365x | +91.56% |
| 2022-12-31 | CN¥4.48 Million ≈ $655.53K |
CN¥-19.37 Million ≈ $-2.83 Million |
-4.324x | -956.52% |
| 2021-12-31 | CN¥64.56 Million ≈ $9.45 Million |
CN¥-26.42 Million ≈ $-3.87 Million |
-0.409x | -354.96% |
| 2020-12-31 | CN¥93.33 Million ≈ $13.66 Million |
CN¥-8.40 Million ≈ $-1.23 Million |
-0.090x | -107.44% |
| 2019-12-31 | CN¥133.33 Million ≈ $19.51 Million |
CN¥161.13 Million ≈ $23.58 Million |
1.209x | +39.51% |
| 2018-12-31 | CN¥81.62 Million ≈ $11.94 Million |
CN¥70.71 Million ≈ $10.35 Million |
0.866x | +240.09% |
| 2017-12-31 | CN¥96.27 Million ≈ $14.09 Million |
CN¥24.52 Million ≈ $3.59 Million |
0.255x | +949.12% |
| 2016-12-31 | CN¥66.18 Million ≈ $9.68 Million |
CN¥1.61 Million ≈ $235.13K |
0.024x | +203.93% |
| 2015-12-31 | CN¥62.76 Million ≈ $9.18 Million |
CN¥-1.47 Million ≈ $-214.52K |
-0.023x | -404.59% |
| 2014-12-31 | CN¥85.25 Million ≈ $12.47 Million |
CN¥653.79K ≈ $95.67K |
0.008x | -94.10% |
| 2013-12-31 | CN¥95.26 Million ≈ $13.94 Million |
CN¥12.37 Million ≈ $1.81 Million |
0.130x | +160.78% |
| 2012-12-31 | CN¥92.76 Million ≈ $13.57 Million |
CN¥-19.82 Million ≈ $-2.90 Million |
-0.214x | -501.81% |
| 2011-12-31 | CN¥182.84 Million ≈ $26.75 Million |
CN¥-6.49 Million ≈ $-950.05K |
-0.036x | +56.56% |
| 2010-12-31 | CN¥154.14 Million ≈ $22.55 Million |
CN¥-12.60 Million ≈ $-1.84 Million |
-0.082x | -302.37% |
| 2009-12-31 | CN¥187.74 Million ≈ $27.47 Million |
CN¥7.58 Million ≈ $1.11 Million |
0.040x | -54.19% |
| 2008-12-31 | CN¥240.30 Million ≈ $35.16 Million |
CN¥21.19 Million ≈ $3.10 Million |
0.088x | -47.51% |
| 2007-12-31 | CN¥282.93 Million ≈ $41.40 Million |
CN¥47.53 Million ≈ $6.96 Million |
0.168x | -28.28% |
| 2006-12-31 | CN¥236.44 Million ≈ $34.60 Million |
CN¥55.39 Million ≈ $8.10 Million |
0.234x | +561.08% |
| 2005-12-31 | CN¥239.39 Million ≈ $35.03 Million |
CN¥8.48 Million ≈ $1.24 Million |
0.035x | +560.32% |
| 2004-12-31 | CN¥252.36 Million ≈ $36.93 Million |
CN¥1.35 Million ≈ $198.17K |
0.005x | +103.17% |
| 2003-12-31 | CN¥242.64 Million ≈ $35.51 Million |
CN¥-41.13 Million ≈ $-6.02 Million |
-0.170x | -296.91% |
| 2002-12-31 | CN¥253.20 Million ≈ $37.05 Million |
CN¥21.80 Million ≈ $3.19 Million |
0.086x | +105.99% |
| 2001-12-31 | CN¥251.63 Million ≈ $36.82 Million |
CN¥10.52 Million ≈ $1.54 Million |
0.042x | +208.63% |
| 2000-12-31 | CN¥251.29 Million ≈ $36.77 Million |
CN¥-9.67 Million ≈ $-1.41 Million |
-0.038x | -119.13% |
| 1999-12-31 | CN¥244.10 Million ≈ $35.72 Million |
CN¥49.09 Million ≈ $7.18 Million |
0.201x | +1911.55% |
| 1998-12-31 | CN¥235.71 Million ≈ $34.49 Million |
CN¥2.36 Million ≈ $344.84K |
0.010x | -- |
About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared sl… Read more